In conclusion, our data indicate that the previously reported CRY1 gene expression differences in LR vs. HR CLL patients [8], [11] are caused by aberrant methylation of the CRY1 promoter in the LR patient subgroup. Here, CRY1 is linked to B-cell chronic lymphocytic leukemia.